Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-020553
Filing Date
2015-11-12
Accepted
2015-11-12 13:17:54
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20150930_10q.htm 10-Q 445695
2 EXHIBIT 10.7 ex10-7.htm EX-10.7 64082
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 16900
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 16707
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 5946
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 5863
  Complete submission text file 0001437749-15-020553.txt   2208048

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS govx-20150930.xml EX-101.INS 282259
8 EXHIBIT 101.SCH govx-20150930.xsd EX-101.SCH 29911
9 EXHIBIT 101.CAL govx-20150930_cal.xml EX-101.CAL 17402
10 EXHIBIT 101.DEF govx-20150930_def.xml EX-101.DEF 191215
11 EXHIBIT 101.LAB govx-20150930_lab.xml EX-101.LAB 144932
12 EXHIBIT 101.PRE govx-20150930_pre.xml EX-101.PRE 207253
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 151223148
SIC: 8731 Services-Commercial Physical & Biological Research